Treatment of diabetic retinopathy: Recent advances and unresolved challenges

doi:10.4239/wjd.v7.i16.333

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14228)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

1510

WORD

365

HTML

7586

Figures (1-2)

234

Tables (1-1)

239

Sum=9934

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

486

Download

1154

Sum=1640

Publishing Process of This Article

Item

Count

Browse

1048

Download

1605

Sum=2653

Aug 25, 2016 (publication date) through Nov 21, 2024

Times Cited of This Article

Times Cited (107)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Diabetes. Aug 25, 2016; 7(16): 333-341
Published online Aug 25, 2016. doi: 10.4239/wjd.v7.i16.333

Full Size Figure Download Figure

Figure 2 This figure shows sequential optical coherence tomography scans of a patient with diabetic macular edema. At baseline (A and B) the patient was given a series of 5 monthly injections of bevacizumab with no significant improvement in macular edema (C and D); one month after a single injection of the dexamethasone delivery system, the volume of edema had significantly improved (E and F).

Citation: Stewart MW. Treatment of diabetic retinopathy: Recent advances and unresolved challenges. World J Diabetes 2016; 7(16): 333-341
URL: https://www.wjgnet.com/1948-9358/full/v7/i16/333.htm
DOI: https://dx.doi.org/10.4239/wjd.v7.i16.333